[Federal Register Volume 84, Number 173 (Friday, September 6, 2019)]
[Notices]
[Page 46961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19293]



[[Page 46961]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on September 25th, 2019, 
from 10:00 a.m. EDT to 4:00 p.m. EDT.
    The board will meet in closed-session on September 25th, 2019, from 
10:00 a.m. EDT to 4:00 p.m. EDT to discuss confidential issues 
surrounding the proposed Mandatory Guidelines for Federal Workplace 
Drug Testing Programs (urine specimens, oral fluid, hair), studies from 
Johns Hopkins Behavioral and Pharmacology Research Unit (BPRU), future 
direction considering the Farm Bill, and potential recommendations to 
the Assistant Secretary for Mental Health and Substance Use regarding 
additional drugs that may be tested for in the future. Therefore, the 
meeting is closed to the public, as determined by the Assistant 
Secretary for Mental Health and Substance Use, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 
10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Matthew Aumen.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: September 25, 2019, from 10:00 a.m. to 4:00 
p.m. EDT: CLOSED.
    Place: Substance Abuse and Mental Health Services 
Administration, 5600 Fishers Lane, Rockville, MD 20857.
    Contact: Matthew Aumen, Program Analyst, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16E61A, Rockville, 
Maryland 20857, Telephone: (240) 276-2419, Email: 
[email protected].

Charles P. LoDico,
Chemist.
[FR Doc. 2019-19293 Filed 9-5-19; 8:45 am]
 BILLING CODE 4162-20-P